USE OF ACID R - (+) - ALFA-LIPOICO, ACID R - (-) - DIHIDROLIPOICO AND METABOLITOS FOR THE TREATMENT OF MELLITUS DIABETES AND ITS SECONDARY EFFECTS.

摘要

THE INVENTION REFERS TO THE USE OF R - (+) - ALPHA LIPONIC ACID, R - (-) - DIHYDROLIPONIC OR METABOLITE ACID AS ITS SALTS, ESTER, AMIDA, FOR THE PREPARATION OF MEDICINES FOR TREATMENT OF MELITUS DIABETES OF THE TYPE I AND TYPE II, RESISTANCE TO COMPENSATED AND UNCOMPENSED INSULIN, OF SUBSEQUENT ILLNESSES OR LATE COMPLICATIONS OF THE MELITUS DIABETES AS FOR EXAMPLE CATARATES, POLYETHOPATHY, NEPHROPATIA AS WELL AS CONSEQUENTIAL DISEASES OR THE COMPLICATION DISEASE. THESE KNOWLEDGE DRUGS MAY BE USED ADVANTAGELY AS WELL ALSO IN COMBINATION WITH OTHER ANTI-DIABETIC DRUGS, ESPECIALLY INSULIN AND / OR WITH ADDITIONAL OR STABILIZING SUBSTANCES OR SUBSTANCES AS VITAMIN CUSTOMIZATION, CORRUPTING, VITAMIN CUSTOMIZATION, NORMALIZATION, VITAMIN CUSTOMIZATION. THE INVENTION REFERS IN ADDITION TO THE USE OF R - (+) - ALPHA - LIPONIC ACID, R - (-) - DIHIDROLIPONIC OR METABOLITE ACID AS WELL AS ITS SALTS, ESTER OR AMIDA, FOR THE PREPARATION OF MEDICATIONS IN THE TREATMENT OF DISEASES WITH LIMITED FUNCTIONS OR REDUCED CONTENT OF GLUCOSE CONVEYOR.